Anthony Hunt, Director at REPLIGEN CORP (RGEN), sold 53,352 shares at $153.70 ($8.1M) on 2025-03-17, disclosed to the SEC on 2025-03-19.
Scheduled sale ($8.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $148.05 | 60 | $9K | 0.1% |
| 2 | $150.38 | 100 | $15K | 0.2% |
| 3 | $151.09 | 2,518 | $380K | 4.7% |
| 4 | $151.09 | 2,518 | $380K | 4.7% |
| 5 | $151.96 | 6,176 | $939K | 11.5% |
| 6 | $151.96 | 6,176 |
| $939K |
| 11.5% |
| 7 | $152.82 | 15,619 | $2.4M | 29.3% |
| 8 | $152.82 | 15,619 | $2.4M | 29.3% |
| 9 | $153.70 | 2,283 | $351K | 4.3% |
| 10 | $153.70 | 2,283 | $351K | 4.3% |
| Total | $152.52 avg | 53,352 | $8.1M | 100% |
| Filing → |
| RGEN | SELL | 2025-09-11 | $7.0M | — | Filing → |
| RGEN | SELL | 2025-05-16 | $6.5M | — | Filing → |
| RGEN | SELL | 2024-11-22 | $6.8M | — | Filing → |